MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
At the MAPS 2022 Global Annual Meeting, MAPS sits down to chat with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about developments in the practice and direction of Medical Affairs in Latin America. Augusto and José are also co-chairs of the MAPS Latin America Chapter.
This webinar will analyze the current state of Medical Affairs in Japan, highlight progress made and provide suggestions on what we can do together to make Medical Affairs in Japan even more effective.
This webinar will be covering:
1.   MA in Japan today: progress and highlights
a.   Leadership requirements in Japan to bring MA to the next level
b.   MA has become more strategic across all companies
c.    What are the competencies required to succeed?
2.   Looking into the future of MA in Japan
a.   How to engage more with Patients/Patient Advocacy groups
b.   How to bring more value to customers, scientific leaders and health systems
c.    How to better engage academia and health authority group through scientific exchange
3.   Opportunities for improving effectiveness
a.   Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
One topic of discussion at the MAPS 2022 Global Annual Meeting was the role of Medical Affairs in patient engagement. Specifically, with patients taking more ownership decisions surrounding care, should Medical Affairs be engaging with patients and/or patient communities in a compliant way? To go even further, should Medical Affairs be the entity within the organization that "owns" patient engagement? Here, Marija Geertsen, VP of Medical Affairs at Lundbeck shares her opinion -- and the story of how her opinion changed during the course of the meeting.
As Medical Affairs professionals, it's easy to focus on the tasks that are right in front of us everyday. In this interview with Monica de Abadal, SVP and Head of Medical Affairs, North America we sat down at the MAPS 2022 Global Annual Meeting to take a step back. Here is how Medical Affairs benefits patients and society. Watch the full interview here.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Medical technologies such as medical devices and diagnostics are set apart from pharmaceuticals in that successful deployment depends on not only equipping health care providers with the theoretical knowledge of best and safest use but also ensuring users’ practical competence. Simply, with medical technologies across the spectrum from noninvasive diagnostics to high-risk therapeutics, clinical outcomes and patient safety depend on both proper education and proper training. In fact, this training is often a gatekeeper for use, as governments, trade organizations, and even hospitals may require medical staff to be adequately trained before new medical devices can be used in their settings. External education and training of health care professionals is largely the responsibility of External Education teams within Medical Affairs. This article details the importance of the External Education function and describes best practices for the implementation of External Education related to medical diagnostics/devices within a manufacturer’s organization.
Medical Affairs describes itself as a third strategic pillar in the biopharmaceutical and MedTech industries alongside R&D and Commercial. But is this truly the case or is Medical Affairs' strategic role still aspirational? And if it is in some ways aspirational, what does Medical Affairs need to do in order to truly achieve its position alongside R&D and Commercial? Here, three Medical Affairs leaders discuss these questions and offer their perspective for the future of the function.